Page 253 - Bio Engineering Approaches to Cancer Diagnosis and Treatment

252 Index

Cancer immunology dendritic cell-based therapy, 119
bioengineering assisted cancer imaging using T cell receptor, cancer therapy with, 117
nonbiological components, 8 tumor-infiltrating lymphocytes, cancer
bioengineering assisted cancer treatment using therapy with, 116
nonbiological components, 9 innate cell-based therapy
cancer and immune system impairment, 3 innate lymphoid cells, 121
cancer stem cell, 2 innate or adaptive immunity, 123
cancer therapy and immunotherapy, 3 NK cells, 121
heat and fluid flow, principles of preclinical and clinical examination of
fluid mechanics, 9 innate cell therapy, 123
heat transfer, 12 magnetic and electric fields, application of
thermodynamics, 16 bioengineering application of
immunoassay diagnosis technics in cancer, 6 electromagnetic fields, 160
Cancer-specific immune response, 70 electromagnetic fields application in drug
Cancer stem cell (CSC), 2 delivery, 162
Cancer testis antigens (CTAs), 98 external magnet on cancerous solid, 171
Cancer therapy, applications in ultrasound governing equations, 161
approved modes for hyperthermia, 166
nonthermal ultrasound therapeutic magnetic nanoparticles properties, 157
applications, 190 progenitor stem cell therapy
thermal ultrasound therapeutic applications, hematopoietic progenitor cells in cancer
186 therapy, 125
ultrasonic waves on tissues and blood, induced pluripotent stem cells in cancer
effects of, 192 therapy, 126
in biomedical engineering, 181 Cell washing, 231
governing equations CFD. See computational fluid dynamics
cardiovascular disease, 206 (CFD)
chemotherapy combination with ultrasound, Chemo immunotherapy
203 chemotherapy, 84
drug carriers for ultrasound drug delivery, clinical examination of, 87
201 mechanisms of, 87
linear ultrasonic relationships, 198 Chemotherapy, 84
sonodynamic therapy, 202 combination with ultrasound, 203
transdermal drug delivery, 206 therapeutic approaches in cancer therapy, 4
ultrasound-mediated gene transfection, 205 Chimeric antigen receptor (CARs)
high intensity focused ultrasound on thermal T cell therapy, 117
ablation, 207 Chlorins, in photodynamic therapy, 142
ultrasonic-activated drug delivery, 200 Chronic lymphocytic leukemia (CLL), 87
Cancer vaccine Circulating autoantibodies, 49
biomaterials in delivery and targeting, 101 Circulating tumor cells (CTCs), 234
DNA/mRNA vaccines, 99 Cleavable linkers, 92
production, 96 CLL. See chronic lymphocytic leukemia
tumor cell vaccines, 100 (CLL)
viral vaccines, 100 Closed system (control mass), 16
Carbon nanotubes, in photothermal therapy, 138 CMC. See complement mediated cytotoxicity
Cardiovascular disease, 206 (CMC)
Carnosine dipeptidase 1 (CNDP1), 54 CNDP1. See carnosine dipeptidase 1 (CNDP1)
CARs. See chimeric antigen receptor (CARs) Commercial iodinated molecules, 25
Cell surface differentiation antigens, 76 Complement mediated cytotoxicity (CMC), 75
Cell therapy Computational fluid dynamics (CFD), 9
adoptive cell-based therapy in combination with Conduction heat transfer, 13
chemotherapy Conservation of mass, 10
chimeric antigen receptor T cell therapy, 117 Conservation of momentum, 10